Latest filing published 08 Sept 2023 for Surface Oncology, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Vito J. Palombella is a declared insider at 2 companies (senior executive); the most frequent names are Infinity Pharmaceuticals, Inc. and Surface Oncology, Inc. The record holds 24 filings, for trades running from 20 June 2013 to 8 September 2023.
Every open-market trade on record is a sale: 11 sales worth €872k. The rest of the record consists of 4 share grants and 8 option exercises.
On 8 September 2023 came the latest disclosure, a transaction in Surface Oncology, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations